• Activity INFORMATION

  Overview

  USP <795> nonsterile compounding standards have recently been revised and approved for implementation in November 2022. This new revision brings many changes that will impact all facilities that compound nonsterile compounds for human and animal patients. This session seeks to discuss the key changes in the USP <795> standards, identify challenges to addressing and implementing these changes, and discuss some strategies for implementing the changes successfully before the enforcement deadline of November 1, 2023.
  

  Handouts

  • Slide Document :   23249H07_2pp.pdf Download

  • Slide Document :   23249H07_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify deadlines for compliance with the current USP <795> standards

  Identify the challenges to implementation of the current USP <795> standards

  Identify the changes in USP <795> presented in the current standards

  Identify strategies to address the challenges to implementation of the current USP <795> standards

  Pharmacy Technician

  Identify strategies to address the challenges to implementation of the current USP <795> standards

  Identify the challenges to implementation of the current USP <795> standards

  Identify deadlines for compliance with the current USP <795> standards

  Identify the changes in USP <795> presented in the current standards

  Nurse

  Identify strategies to address the challenges to implementation of the current USP <795> standards

  Identify the challenges to implementation of the current USP <795> standards

  Identify deadlines for compliance with the current USP <795> standards

  Identify the changes in USP <795> presented in the current standards

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1125576

  Universal Activity Number

  Pharmacist 0798-0000-23-249-H07-P
  Pharmacy Technician 0798-0000-23-249-H07-T
  Nurse 0798-0000-23-249-H07-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Steven  Ziegler, PharmD, MBA President/Co-Owner, Pharmacist-in-Charge, Moss Compounding Pharmacy

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).